Oculis Holding AG Ordinary shares (OCS) is a publicly traded Healthcare sector company. As of September 17, 2026, OCS trades at $9.97 with a market cap of $550.28M and a P/E ratio of 0.00. OCS moved +0.66% today. Year to date, OCS is -50.10%; over the trailing twelve months it is -42.64%. Its 52-week range spans $9.65 to $34.48. Analyst consensus is strong buy with an average price target of $34.57. Rallies surfaces OCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for OCS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $9.97 |
| Market Cap | $550.28M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $34.48 |
| 52-Week Low | $9.65 |
| Volume | 220.04K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
7 analysts cover OCS: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.57.